Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ana Rita da Fonseca"'
Publikováno v:
CIÊNCIAVITAE
Dissertação para obtenção do grau de Mestre no Instituto Universitário Egas Moniz Introdução: Atualmente, assistimos a um envelhecimento da população, bem como a um aumento da prevalência e severidade da doença periodontal. Associações t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b85da7b4df6fcfd6a68f5fdf47e2409b
https://hdl.handle.net/10400.26/43154
https://hdl.handle.net/10400.26/43154
Autor:
Mariana Serpa, Vanderson Rocha, Vinicius Campos de Molla, Roberta Shcolnik Szor, Giancarlo Fatobene, Luciana Tucunduva, André Domingues Pereira, Ana Rita Da Fonseca, Celso Arrais-Rodrigues, Erick Xavier, Erika Yuri Hirose, Yana Novis, Matheus Vescovi Gonçalves
Publikováno v:
Clinical Nutrition ESPEN. 33:213-219
Summary Background Malnutrition is a common finding in allogeneic hematopoietic stem cell transplantation (alloHSCT) patients, and there is some evidence that malnutrition might negatively affect the transplant outcomes. Method We performed a retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::984769d26bedd6ab0509e80869546628
https://doi.org/10.1016/j.clnesp.2019.05.005
https://doi.org/10.1016/j.clnesp.2019.05.005
Autor:
André Domingues Pereira, Vinicius Campos de Molla, Ana Flavia Popi, Yana Novis, Ana Rita Da Fonseca, Celso Arrais-Rodrigues, Marcela Souza Pires
Publikováno v:
Blood. 136:1-2
Introduction: Hematopoietic stem cell transplantation (HSCT) is the only potentially curative treatment for several diseases. Immune reconstitution post HSCT is a complex and extremely variable process. Ikaros transcription factor has an important ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::390ca3ca5a8bd59fe49d720335d9a3ce
https://doi.org/10.1182/blood-2020-138981
https://doi.org/10.1182/blood-2020-138981
Autor:
Ana Rita Da Fonseca, Mariana Serpa, Maria Cristina Nunez Seiwald, Erick Xavier, Luciana Tucunduva, Roberta Shcolnik Szor, Celso Arrais-Rodrigues, Aliana Meneses Ferreira, Pedro Henrique Arruda De Moraes, Vinicius Campos de Molla, Yana Novis
Publikováno v:
Blood. 136:40-41
Introduction: Chronic graft-versus-host disease (cGVHD) remains a major barrier to a successful hematopoietic stem cell transplantation (HSCT), associated with significant morbidity, increased risk of infection, and reduced quality of life. In cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97ca31f3d04dc49ccd4ce31dbc035144
https://doi.org/10.1182/blood-2020-141452
https://doi.org/10.1182/blood-2020-141452
Increased Risk of for Cytomegalovirus Reactivation after Allogeneic HSCT in T-Cell Depleted Patients
Autor:
Roberta Azevedo, Celso Arrais, Vanderson Rocha, Rayana Bomfim Leonel, Ana Rita Da Fonseca, Maria Cristina Nunez Seiwald, Roberta Shcolnik Szor, Mariana Serpa, Yana Novis, Danilo Belchior Ponciano, Erick Xavier, Aliana Meneses Ferreira, Marcio Nucci, Vinicius Campos de Molla, Esper G. Kallas, Luciana Tucunduva, Pedro Henrique Arruda De Moraes, Jessica Fernandes Ramos
Publikováno v:
Blood. 136:36-37
Background: Reactivation of Cytomegalovirus (CMV) is frequent after allogeneic hematopoietic stem cell transplantation (HSCT), occurring in approximately 70% of CMV seropositive patients. CMV reactivation is associated with higher non-relapse mortali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1037e98c7047830ea0e4108e2031f687
https://doi.org/10.1182/blood-2020-142111
https://doi.org/10.1182/blood-2020-142111
Autor:
Fernanda de Morais Marques, Talita Silveira, Valeria Buccheri, Vinicius Campos de Molla, Rodrigo Santucci Silva, Marcelo Bellesso, Ana Rita Da Fonseca, Sérgio Costa Fortier, Guilherme Duffles Amarante, Matheus Vescovi, Verena Pfister, Celso Arrais, Mihoko Yamamoto, Carlos S. Chiattone, Flavia Parra, Yana Novis
Publikováno v:
Blood. 136:12-12
Introduction: Some patients with CLL will require treatment at diagnosis, but many other will remain untreated under observation for several years. In 2008, the International Workshop on Chronic Lymphocytic Leukemia(IWCLL) defined the criteria for tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ae724bc7f819f6158f2addc33658b5c
https://doi.org/10.1182/blood-2020-142810
https://doi.org/10.1182/blood-2020-142810
T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells
Autor:
Gennaro Riccio, Valentina Rubino, Margherita Passariello, Ana Rita Da Fonseca Ricardo, Claudia De Lorenzo, Kathy Saraiva, Nico Mertens, Philip Cunnah
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 42(1)
The Tyrosine Kinase Receptor ErbB2 (HER2) when overexpressed in breast cancer (BC) is associated with poor prognosis. The monoclonal antibody Trastuzumab has become a standard treatment of ErbB2+BC. The antibody treatment has limited efficacy, often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acef4950fb9a448e08e3602b9f818cc3
https://pubmed.ncbi.nlm.nih.gov/30520849
https://pubmed.ncbi.nlm.nih.gov/30520849
Autor:
Fernando Sergio Blumm Ferreira, Gislaine B. Oliveira, Larissa Ommati, Vera Lucia de Piratininga Figueiredo, Matheus Vescovi, Sérgio Costa Fortier, Valeria Buccheri, Nayara Ribeiro Guedes, Leila Martins Perobelli, Vinicius Campos de Molla, Rodrigo Santucci Silva, Thiago Xavier Carneiro, Celso Arrais-Rodrigues, Ana Rita Da Fonseca
Publikováno v:
Blood. 134:1764-1764
Introduction Given the variety of highly effective therapies available for chronic lymphocytic leukemia (CLL), a tailored treatment strategy is needed. Fixed-duration chemoimmunotherapy can produce sustained and deep responses. The presence of minima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c7420408a4168417627a5f45bacf769
https://doi.org/10.1182/blood-2019-125626
https://doi.org/10.1182/blood-2019-125626
Autor:
Celso Arrais-Rodrigues, Matheus Vescovi, Ana Rita Da Fonseca, Patricia Eiko Yamakawa, Iara Baldim Rabelo Gomes, Ismael Dale Cotrim Guerreiro da Silva
Publikováno v:
Blood. 134:2229-2229
Introduction: Paroxysmal nocturnal hemoglobinuria (PNH) is a non-malignant clonal disease of hematopoietic cells with a complex pathophysiology and variable clinical spectrum, characterized by signs and symptoms related to intravascular hemolysis, hy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::686eaea29a11879383d9977b118bc8e7
https://doi.org/10.1182/blood-2019-126241
https://doi.org/10.1182/blood-2019-126241